Yilmaz Mahshid — CFO
Get alerts when Yilmaz Mahshid trades
Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Egetis Therapeutics AB (publ).
12-month summary
Net seller over the last 12 months
1 open-market buy, 1 sale, 2 share awards · SEK 232,266.00 bought, SEK 998,601.50 sold
Roles
15.07.2025 – 31.08.2026
Transactions (including via associated entities)
| Date | Issuer | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 31.08.2026 | Egetis Therapeutics AB (publ) Stockholm | Share award | 1,099 | — | Share award 1,099 shares | ↗ |
| 13.05.2026 | Egetis Therapeutics AB (publ) Stockholm | SoldDisposal | 153,631 | SEK 6.50 | SEK 998,601.50 | ↗ |
| 11.05.2026 | Egetis Therapeutics AB (publ) Stockholm | Share award | 264,880 | — | Share award 264,880 shares | ↗ |
| 26.11.2025✎ | Egetis Therapeutics AB (publ) Stockholm | Bought — open marketAcquisition | 60,000 | SEK 3.87 | SEK 232,266.00 | ↗ |
| 15.07.2025 | Egetis Therapeutics AB (publ) Stockholm | Bought — open marketAcquisition | 35,000 | SEK 5.38 | SEK 188,300.00 | ↗ |